Journal of Shandong University (Health Sciences) ›› 2024, Vol. 62 ›› Issue (2): 60-68.doi: 10.6040/j.issn.1671-7554.0.2023.1044
• Clinical Medicine • Previous Articles
DIAO Yujie1, LIN Lin2, LI Wenxuan1, WANG Zhouyang1, JIANG Bei1, HU Yingying3, LIU Guangyi1
CLC Number:
[1] Yates M, Watts R. ANCA-associated vasculitis[J]. Clin Med(Lond), 2017, 17(1): 60-64. [2] Kronbichler A, Lee KH, Denicolò S, et al. Immunopathogenesis of ANCA-associated vasculitis[J]. Int J Mol Sci, 2020, 21(19): E7319. [3] Kitching AR, Anders HJ, Basu N, et al. ANCA-associated vasculitis[J]. Nat Rev Dis Primers, 2020, 6(1): 71. [4] Geetha D, Jefferson JA. ANCA-associated vasculitis: core curriculum 2020[J]. Am J Kidney Dis, 2020, 75(1): 124-137. [5] Sánchez álamo B, Moi L, Bajema I, et al. Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis[J]. Nephrol Dial Transplant, 2023, 38(7): 1655-1665. [6] Sagmeister MS, Grigorescu M, Schönermarck U. Kidney transplantation in ANCA-associated vasculitis[J]. J Nephrol, 2019, 32(6):919-926. [7] 胡浪涛, 魏佳莉. 抗中性粒细胞胞浆抗体相关性血管炎的治疗新进展[J]. 内科急危重症杂志, 2023, 29(2): 151-155. [8] Emejuaiwe N. Treatment strategies in ANCA-associated vasculitis[J]. Curr Rheumatol Rep, 2019, 21(7): 33. [9] Monti S, Brandolino F, Milanesi A, et al. Novel therapies for ANCA-associated vasculitis[J]. Curr Rheumatol Rep, 2021, 23(6): 38. [10] Binda V, Moroni G, Messa P. ANCA-associated vasculitis with renal involvement[J]. J Nephrol, 2018, 31(2): 197-208. [11] 陈燕燕, 欧希龙. 中性粒细胞影响炎症反应的受控因素及与机体损伤关系[J]. 东南大学学报(医学版), 2013, 32(4): 511-514. CHEN Yanyan, OU Xilong. Controlled factors of neutrophils affecting inflammatory response and their relationship with body injury[J]. Journal of Southeast University(Medical Science Edition), 2013, 32(4): 511-514. [12] Djordjevic D, Rondovic G, Surbatovic M, et al. Neutrophil-to-Lymphocyte Ratio, Monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume-to-platelet count ratio as biomarkers in critically ill and injured patients: which ratio to choose to predict outcome and nature of bacteremia?[J]. Mediators Inflamm, 2018, 2018: 3758068. doi: 10.1155/2018/3758068. [13] Semple JW, Italiano JE, Freedman J. Platelets and the immune continuum[J]. Nat Rev Immunol, 2011, 11: 264-274. doi: 10.1038/nri2956. [14] Willeke P, Kümpers P, Schlüter B, et al. Platelet counts as a biomarker in ANCA-associated vasculitis[J]. Scand J Rheumatol, 2015, 44(4): 302-308. [15] Banka AL, Guevara MV, Brannon ER, et al. Cargo-free particles divert neutrophil-platelet aggregates to reduce thromboinflammation[J]. Nat Commun, 2023, 14: 2462. doi: 10.1038/s41467-023-37990-z. [16] 朱晓明, 李奎宝, 卢长林, 等. 中性粒细胞/血小板计数比值对接受连续性肾脏替代治疗的心血管疾病危重患者预后的评估价值[J]. 中国心血管杂志, 2022, 27(3): 258-262. ZHU Xiaoming, LI Kuibao, LU Changlin, et al. Neutrophil to platelet ratio: a novel prognostic biomarker in patients with critical cardiovascular disease received continuous renal replacement therapy[J]. Chinese Journal of Cardiovascular Medicine, 2022, 27(3): 258-262. [17] Pang J, Liu J, Liang W, et al. High neutrophil-to-platelet ratio is associated with poor survival in patients with acute aortic dissection[J]. Dis Markers, 2022, 2022: 5402507. doi: 10.1155/2022/5402507. [18] Lin Y, Dai W, Chen Y, et al. Neutrophil-to-platelet ratio predicts mortality following percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction[J]. Front Physiol, 2022, 13: 1011048. doi: 10.3389/fphys.2022.1011048. [19] 周宇, 刘卓然, 梅名强, 等. 中性粒细胞与淋巴细胞和血小板比值联合评分对于肝细胞癌切除术后的预后预测价值[J]. 中国普外基础与临床杂志, 2023, 30(8): 970-973. [20] Sinico RA, Di Toma L, Radice A. Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis[J]. Autoimmun Rev, 2013, 12(4): 477-482. [21] Chen D, Xiao D, Guo JC, et al. Neutrophil–lymphocyte count ratio as a diagnostic marker for acute kidney injury: a systematic review and meta-analysis[J]. Clin Exp Nephrol, 2020, 24(2): 126-135. [22] 黄静麟, 王宝娟. ANCA相关性血管炎合并肝损伤病例报道1例[J]. 医学理论与实践, 2023, 36(11): 1916-1917. [23] Willeke P, Schlüter B, Limani A, et al. Liver involvement in ANCA-associated vasculitis[J]. Clin Rheumatol, 2016, 35(2): 387-394. [24] Ahn SS, Yoon T, Song JJ, et al. Serum albumin, prealbumin, and ischemia-modified albumin levels in patients with ANCA-associated vasculitis: a prospective cohort study[J]. PLoS One, 2022, 17(7): e0271055. [25] He W, Ruan Y, Yuan C, et al. High neutrophil-to-platelet ratio is associated with hemorrhagic transformation in patients with acute ischemic stroke[J]. Front Neurol, 2019, 10: 1310. doi: 10.3389/fneur.2019.01310. [26] Wei XB, Liu YH, He PC, et al. The impact of admission neutrophil-to-platelet ratio on in-hospital and long-term mortality in patients with infective endocarditis[J]. Clin Chem Lab Med, 2017, 55(6): 899-906. [27] Shaafi S, Bonakdari E, Sadeghpour Y, et al. Correlation between red blood cell distribution width, neutrophil to lymphocyte ratio, and neutrophil to platelet ratio with 3-month prognosis of patients with intracerebral hemorrhage: a retrospective study[J]. BMC Neurol, 2022, 22(1): 191. [28] Foy BH, Sundt TM, Carlson JCT, et al. Human acute inflammatory recovery is defined by co-regulatory dynamics of white blood cell and platelet populations[J]. Nat Commun, 2022, 13(1): 4705. [29] Tsirpanlis G. The pattern of inflammation and a potential new clinical meaning and usefulness of C-reactive protein in end-stage renal failure patients[J]. Kidney Blood Press Res, 2005, 28(1): 55-61. [30] Ahn SS, Park YB, Lee SW. Serological biomarkers and indices for the current activity and prognosis of ANCA-associated vasculitis: experience in a single centre in Korea[J]. Yonsei Med J, 2021, 62(4): 279-287. [31] Ahn SS, Jung SM, Song JJ, et al. Neutrophil to lymphocyte ratio at diagnosis can estimate vasculitis activity and poor prognosis in patients with ANCA-associated vasculitis: a retrospective study[J]. BMC Nephrol, 2018, 19(1): 187. [32] Fonseca JA, Gameiro J, Duarte I, et al. The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: a retrospective study[J]. Nefrologia(Engl Ed), 2021, 41(3): 321-328. [33] Crnogorac M, Horvatic I, Toric L, et al. Clinical, serological and histological determinants of patient and renal outcome in ANCA-associated vasculitis with renal involvement: an analysis from a referral centre[J]. Int Urol Nephrol, 2017, 49(8): 1419-1431. [34] Baier E, Tampe D, Hakroush S, et al. Low levels of hemoglobin associate with critical illness and predict disease course in patients with ANCA-associated renal vasculitis[J]. Sci Rep, 2022, 12: 18736. doi: 10.1038/s41598-022-23313-7. [35] Kawamura T, Usui J, Kaneko S, et al. Anaemia is an essential complication of ANCA-associated renal vasculitis: a single center cohort study[J]. BMC Nephrol, 2017, 18(1): 337. [36] Palaka E, Grandy S, van Haalen H, et al. The impact of CKD anaemia on patients: incidence, risk factors, and clinical outcomes-a systematic literature review[J]. Int J Nephrol, 2020, 2020: 7692376. doi: 10.1155/2020/7692376. |
[1] | WANG Zhouyang, JIANG Bei, LI Xianhua, ZHEN Junhui, YANG Xiangdong, HU Zhao, LIU Guangyi, PEI Fei. A case of infective endocarditis and acute kidney injury with positive PR3-ANCA [J]. Journal of Shandong University (Health Sciences), 2022, 60(2): 60-64. |
|